C. Dormuth

First name
Middle name
Last name
Dormuth, C. R., Hemmelgarn, B. R., Paterson, J. M., James, M. T., Teare, G. F., Raymond, C. B., et al. (2013). Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases. Bmj. http://doi.org/10.1136/bmj.f880
Filion, K. B., Chateau, D., Targownik, L. E., Gershon, A., Durand, M., Tamim, H., et al. (2014). Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis. Gut. http://doi.org/10.1136/gutjnl-2013-304738
Renoux, C., Lix, L. M., Patenaude, V., Bresee, L. C., Paterson, J. M., Lafrance, J. P., et al. (2015). Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis. Clin J Am Soc Nephrol. http://doi.org/10.2215/cjn.11271114
Filion, K. B., Azoulay, L., Platt, R. W., Dahl, M., Dormuth, C. R., Clemens, K. K., et al. (2016). A Multicenter Observational Study of Incretin-based Drugs and Heart Failure. N Engl J Med. http://doi.org/10.1056/NEJMoa1506115
Secrest, M. H., Platt, R. W., Reynier, P., Dormuth, C. R., Benedetti, A., & Filion, K. B. (2019). Multiple imputation for systematically missing confounders within a distributed data drug safety network: A simulation study and real-world example. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4876
Secrest, M. H., Platt, R. W., Dormuth, C. R., Chateau, D., Targownik, L., Nie, R., et al. (2019). Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4708
Dormuth, C. R., Winquist, B., Fisher, A., Wu, F., Reynier, P., Suissa, S., et al. (2021). Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort. JAMA Netw Open. http://doi.org/10.1001/jamanetworkopen.2021.5329